Simvastatin maintains steady patterns of GFR and improves AER and expression of slit diaphragm proteins in type II diabetes.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Kidney International

• Publication date

  2006-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/SJ.KI.5001515PMID 16710349
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hereditary proteinuria syndromes and mechanisms of proteinuria.

  2006cited by this paper
• Effects of increasing doses of simvastatin on fasting lipoprotein subfractions, and the effect of high-dose simvastatin on postprandial chylomicron remnant clearance in normotriglyceridemic patients with premature coronary sclerosis.

  2005cited by this paper
• Statins for atherosclerosis--as good as it gets?

  2005cited by this paper
• Modeling GFR trajectories in diabetic nephropathy.

  2005cited by this paper
• Postprandial hyperglycemia and diabetes complications: is it time to treat?

  2005cited by this paper
• Altered transcapillary escape of albumin and microalbuminuria reflects two different pathogenetic mechanisms.

  2005cited by this paper
• Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy.

  2004cited by this paper
• Regression of microalbuminuria in type 1 diabetes.

  2003cited by this paper
• A new automated method to analyze urinary 8-hydroxydeoxyguanosine by a high-performance liquid chromatography-electrochemical detector system.

  2003cited by this paper
• American Heart Association guide for improving cardiovascular health at the community level: a statement for public health practitioners, healthcare providers, and health policy makers from the American Heart Association Expert Panel on Population and Prevention Science.

  2003cited by this paper
• Invited Review: Oxidation of Biological Systems: Oxidative Stress Phenomena, Antioxidants, Redox Reactions, and Methods for Their Quantification

  2002cited by this paper
• Update in podocyte biology

  2001cited by this paper
• Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.

  2001cited by this paper
• Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.

  2001cited by this paper
• Molecular basis of glomerular permselectivity

  2001cited by this paper
• Caught flat-footed: podocyte damage and the molecular bases of focal glomerulosclerosis.

  2001cited by this paper
• Effect of lipid reduction on the progression of renal disease: a meta-analysis.

  2001cited by this paper
• Age and duration of follow-up as modulators of the risk for ischemic heart disease associated with high plasma C-reactive protein levels in men.

  2001cited by this paper
• Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin.

  2001cited by this paper
• Additive effects of Simvastatin beyond its effects on LDL cholesterol in hypertensive type 2 diabetic patients

  2000cited by this paper
• Omacor in familial combined hyperlipidemia: effects on lipids and low density lipoprotein subclasses.

  2000cited by this paper
• Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate.

  2000cited by this paper
• Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss.

  2000cited by this paper
• Reduction of Albumin Excretion Rate in Normotensive Microalbuminuric Type 2 Diabetic Patients During Long-Term Simvastatin Treatment

  1997cited by this paper
• Synaptopodin: An Actin-associated Protein in Telencephalic Dendrites and Renal Podocytes

  1997cited by this paper
• Analysis of a form of oxidative DNA damage, 8-hydroxy-2'-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis.

  1997cited by this paper
• Plasma clearance rate of 51Cr-EDTA provides a precise and convenient technique for measurement of glomerular filtration rate in diabetic humans.

  1996cited by this paper
• Patterns of renal injury in NIDDM patients with microalbuminuria

  1996cited by this paper
• The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group.

  1993cited by this paper
• Diabetes Control and Complications Trial

  1993cited by this paper
• Varying susceptibility of different low density lipoproteins to oxidative modification.

  1991cited by this paper
• Diabetes Control and Complications Trial (DCCT): Update

  1990cited by this paper
• Incidence of proteinuria in type 2 diabetes mellitus in the Pima Indians.

  1989cited by this paper
• Hydroxylation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents.

  1984cited by this paper
• Structural-functional relationships in diabetic nephropathy.

  1984cited by this paper
• Clinical Trials: A Practical Approach

  1984cited by this paper
• The kidney in maturity onset diabetes mellitus: a clinical study of 510 patients.

  1982cited by this paper
• Creatinine assay by a reaction-kinetic principle.

  1972cited by this paper
• Dynamics of Spindle Formation and Its Inhibition by Chemicals

  1959cited by this paper

• CD36-mediated podocyte lipotoxicity promotes foot process effacement

  2024cites this paper
• A Strategic Investigation on Diabetic Nephropathy; Its Conceptual Model and clinical Manifestations: A Review.

  2022cites this paper
• Computerized Clinical Decision Support

  2022cites this paper
• Epigenetic Alterations in Podocytes in Diabetic Nephropathy

  2021cites this paper
• Diabetic nephropathy: A twisted thread to unravel.

  2021cites this paper
• Evaluation of Antihyperglycemic Effect of Epilobium parviflorum in High Fat Diet Fructose Streptozotocin Induced Type 2 Diabetic Albino Wistar Rats

  2021cites this paper
• Chronic kidney disease in type 2 diabetes: Implications for managing glycaemic control, cardiovascular and renal risk

  2020cites this paper
• Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities

  2020cites this paper
• An updated overview of diabetic nephropathy: Diagnosis, prognosis, treatment goals and latest guidelines

  2020cites this paper
• OP-NDTJ180344 1681..1738

  2019cites this paper
• Effect of Simvastatin on Lipid Accumulation and the Expression of CXCL16 and Nephrin in Podocyte Induced by Oxidized LDL

  2018cites this paper
• Effect of statins on oxidative DNA damage in diabetic polyneuropathy

  2018cites this paper
• Effect of diacerein on renal function and inflammatory cytokines in participants with type 2 diabetes mellitus and chronic kidney disease: A randomized controlled trial

  2017cites this paper
• Lipotoxicity and kidney Lipotoxicidade e rim

  2016cites this paper
• Simvastatin ameliorates renal lipidosis through the suppression of renal CXCL16 expression in mice with adriamycin-induced nephropathy.

  2015cites this paper
• The novella about diabetic nephropathy.

  2015cites this paper
• Improvements in the Management of Diabetic Nephropathy.

  2015cites this paper
• Diabetic nephropathy – complications and treatment

  2014cites this paper
• HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis

  2014cites this paper
• Novel effective drugs for diabetic kidney disease? or not?

  2014cites this paper
• Vascular Complications of Diabetes Mellitus

  2014cites this paper
• Podocytopathy in Diabetes: A Metabolic Disorder

  2014cites this paper
• Computerized Clinical Decision Support for Patients with Diabetes and Chronic Kidney Disease

  2014cites this paper
• Cholesterol Contributes to Diabetic Nephropathy through SCAP-SREBP-2 Pathway

  2013cites this paper
• Pathophysiology and Complications of Diabetes Mellitus

  2012cites this paper
• Pentoxifylline for diabetic kidney disease.

  2012cites this paper
• Ezetimibe ameliorates early diabetic nephropathy in db/db mice.

  2012cites this paper
• Therapeutic Modalities in Diabetic Nephropathy: Future Approaches.

  2012cites this paper
• Role of oxidized low density lipoproteins and free fatty acids in the pathogenesis of glomerulopathy and tubulointerstitial lesions in type 2 diabetes.

  2011cites this paper
• Differential effect of statins on diabetic nephropathy in db/db mice.

  2011cites this paper
• Association of statin use and development of renal dysfunction in type 2 diabetes--the Hong Kong Diabetes Registry.

  2010cites this paper
• Approach to the patient with type 2 diabetes and progressive kidney disease.

  2010cites this paper
• The pleiotropic actions of rosuvastatin confer renal benefits in the diabetic Apo-E knockout mouse.

  2010cites this paper
• CHAPTER 30 – Prevention and Treatment of Diabetic Nephropathy

  2010cites this paper
• Acute Effects of Atorvastatin on Glomerular Filtration Rate, Tubular Function, Blood Pressure, and Vasoactive Hormones in Patients With Type 2 Diabetes

  2010cites this paper
• Fluvastatin prevents podocyte injury in a murine model of HIV-associated nephropathy.

  2009cites this paper
• Clinical trials of the past decade in the management of chronic kidney disease.

  2009cites this paper
• The decline of glomerular function is not always associated with the development of micro- and macroalbuminuria in hypertensive patients with type 2 diabetes

  2008cites this paper
• Recent Progress in the Pathogenesis of Nephrotic Proteinuria

  2008cites this paper
• Effects of HMG-CoA reductase inhibitors (statins) on progression of kidney disease.

  2008cites this paper
• Aspectos diferenciales del manejo del paciente diabético con insuficiencia renal en diálisis peritoneal o hemodiálisis Differential aspects in management of diabetic patient with renal insufficiency under peritoneal dialysis or hemodialysis

  2008cites this paper
• WITHDRAWN: The decline of glomerular function is not always associated with the development of micro- and macroalbuminuria in hypertensive patients with type 2 diabetes.

  2008cites this paper
• Effect of statins on soluble CD40 ligand in hypercholesterolemic Type 2 diabetic patients

  2008cites this paper
• Update on the Treatment of Diabetic Retinopathy

  2008cites this paper
• Atorvastatin does not induce glomerular or tubular dysfunction even at high doses.

  2007cites this paper
• Will the addition of pentoxifylline reduce proteinuria in patients with diabetic glomerulosclerosis refractory to maximal doses of both an angiotensin-converting enzyme inhibitor and an angiotensin receptor blocker?

  2007cites this paper
• Effects of statins on renal function.

  2007cites this paper
• Clinical Trials and Management of Chronic Kidney Disease

  2006cites this paper
• Effects of statins on renal function.

  2006cites this paper
• Clinical Trials in Asia Pacifi

  year unknowncites this paper